Sign in

Publications

Search in 13060 publications:

Reset RSS
Time frame
11579 Publication(s)
Nov 12, 2023
A Literature Review of Racial Disparities in Prostate Cancer Research.
Vermeille M, Koster K, Benzaquen D, Champion A, Taussky D, Kaulanjan K, Früh M. A Literature Review of Racial Disparities in Prostate Cancer Research. Curr Oncol 2023; 30:9886-9894.
Nov 12, 2023
A Literature Review of Racial Disparities in Prostate Cancer Research.
Nov 12, 2023

Curr Oncol 2023; 30:9886-9894

Vermeille Matthieu, Koster Kira-Lee, Benzaquen David, Champion Ambroise, Taussky Daniel, Kaulanjan Kevin, Früh Martin

more
Nov 10, 2023
Cerebral Microbleeds and Asundexian in Non-cardioembolic Ischemic Stroke: Secondary Analyses of the PACIFIC-STROKE Randomized Trial.
Balali P, Hart R, Smith E, Saad F, Colorado P, Lemmens R, De Marchis G, Caso V, Xu L, Heenan L, Connolly S, Mundl H, Shoamanesh A. Cerebral Microbleeds and Asundexian in Non-cardioembolic Ischemic Stroke: Secondary Analyses of the PACIFIC-STROKE Randomized Trial. Int J Stroke 2023:17474930231216339.
Nov 10, 2023
Cerebral Microbleeds and Asundexian in Non-cardioembolic Ischemic Stroke: Secondary Analyses of the PACIFIC-STROKE Randomized Trial.
Nov 10, 2023

Int J Stroke 2023:17474930231216339

Balali Pargol, Hart Robert G, Smith Eric Edward, Saad Feryal, Colorado Pablo, Lemmens Robin, De Marchis Gian Marco, Caso Valeria, Xu Lizhen, Heenan Laura, Connolly Stuart J, Mundl Hardi, Shoamanesh Ashkan

more
Nov 10, 2023
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Pfob A, Cai L, Schneeweiss A, Rauch G, Thomas B, Schaefgen B, Kümmel S, Reimer T, Hahn M, Thill M, Blohmer J, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Degenhardt T, Rom J, Rody A, van Mackelenbergh M, Banys-Paluchowski M, Große R, Reinisch M, Karsten M, Sidey-Gibbons C, Wallwiener M, Golatta M, Heil J. Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept. Ann Surg Oncol 2023
Nov 10, 2023
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Nov 10, 2023

Ann Surg Oncol 2023

Pfob André, Cai Lie, Schneeweiss Andreas, Rauch Geraldine, Thomas Bettina, Schaefgen Benedikt, Kümmel Sherko, Reimer Toralf, Hahn Markus, Thill Marc, Blohmer Jens-Uwe, Hackmann John, Malter Wolfram, Bekes Inga, Friedrichs Kay, Wojcinski Sebastian, Joos Sylvie, Paepke Stefan, Degenhardt Tom, Rom Joachim, Rody Achim, van Mackelenbergh Marion T, Banys-Paluchowski Maggie, Große Regina, Reinisch Mattea, Karsten Maria Margarete, Sidey-Gibbons Chris, Wallwiener Markus, Golatta Michael, Heil Jörg

more
Nov 10, 2023
Current state of preoperative embolization for spinal metastasis - A survey by the EANS spine section.
Motov S, Stengel F, Ringel F, Oliver B, Stienen M. Current state of preoperative embolization for spinal metastasis - A survey by the EANS spine section. Brain Spine 2023; 3:102712.
Nov 10, 2023
Current state of preoperative embolization for spinal metastasis - A survey by the EANS spine section.
Nov 10, 2023

Brain Spine 2023; 3:102712

Motov Stefan, Stengel Felix C, Ringel Florian, Oliver Bozinov, Stienen Martin N.

more
Nov 9, 2023
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans J, Sylvester R, Anson-Cartwright L, Glicksman R, Hamilton R, Hahn E, Daugaard G, Lauritsen J, Wagner T, Avuzzi B, Nicolai N, del Muro X, Aparicio J, Stalder O, Rothermundt C, Fischer S, Laguna M. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office. Eur Urol Oncol 2023
Nov 9, 2023
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Nov 9, 2023

Eur Urol Oncol 2023

Boormans Joost L, Sylvester Richard, Anson-Cartwright Lynn, Glicksman Rachel M, Hamilton Robert J, Hahn Ezra, Daugaard Gedske, Lauritsen Jakob, Wagner Thomas, Avuzzi Barbara, Nicolai Nicola, del Muro Xavier Garcia, Aparicio Jorge, Stalder Odile, Rothermundt Christian, Fischer Stefanie, Laguna Maria P

more
Nov 8, 2023
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial.
Wildiers H, Armstrong A, Cuypere E, Dalenc F, Dirix L, Chan S, Marme F, Schröder C, Huober J, Duhoux F, Vuylsteke P, Jager A, Brain E, Kümmel S, Pápai Z, Menke-van der Houven van Oordt C, Perjesi L, Mueller A, Brignone C, Triebel F. Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial. Clin Cancer Res 2023
Nov 8, 2023
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial.
Nov 8, 2023

Clin Cancer Res 2023

Wildiers Hans, Armstrong Anne, Cuypere Eveline, Dalenc Florence, Dirix Luc, Chan Stephen, Marme Frederik, Schröder Carolina P, Huober Jens, Duhoux Francois P, Vuylsteke Peter, Jager Agnes, Brain Etienne, Kümmel Sherko, Pápai Zsuzsanna, Menke-van der Houven van Oordt Catharina Willemien, Perjesi Luca, Mueller Arndt-Christian, Brignone Chrystelle, Triebel Frederic

more
Nov 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)].
Otto-Knapp R, Bauer T, Brinkmann F, Feiterna-Sperling C, Friesen I, Geerdes-Fenge H, Hartmann P, Häcker B, Hauer B, Haas W, Heyckendorf J, Kuhns M, Lange C, Maurer F, Nienhaus A, Priwitzer M, Richter E, Salzer H, Schoch O, Schönfeld N, Schaberg T. [Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. Pneumologie 2023
Nov 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)].
Nov 6, 2023

Pneumologie 2023

Otto-Knapp Ralf, Bauer Torsten, Brinkmann Folke, Feiterna-Sperling Cornelia, Friesen Inna, Geerdes-Fenge Hilte, Hartmann Pia, Häcker Brit, Hauer Barbara, Haas Walter, Heyckendorf Jan, Kuhns Martin, Lange Christoph, Maurer Florian P, Nienhaus Albert, Priwitzer Martin, Richter Elvira, Salzer Helmut J F, Schoch Otto, Schönfeld Nicolas, Schaberg Tom

more
Nov 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Abdelhak A, Benkert P, Schaedelin S, Boscardin W, Cordano C, Oechtering J, Ananth K, Granziera C, Melie-Garcia L, Montes S, Beaudry-Richard A, Achtnichts L, Oertel F, Lalive P, Leppert D, Müller S, Henry R, Pot C, Matthias A, Salmen A, Oksenberg J, Giulio D, Zecca C, D'Souza M, Du Pasquier R, Bridel C, Gobbi C, Kappos L, Hauser S, Cree B, Kuhle J, Green A, UCSF, MS EPIC, and the SMSC Study Teams. Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurol 2023
Nov 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Nov 6, 2023

JAMA Neurol 2023

Abdelhak Ahmed, Benkert Pascal, Schaedelin Sabine A, Boscardin W John, Cordano Christian, Oechtering Johanna, Ananth Kirtana, Granziera Cristina, Melie-Garcia Lester, Montes Shivany Condor, Beaudry-Richard Alexandra, Achtnichts Lutz, Oertel Frederike C, Lalive Patrice H, Leppert David, Müller Stefanie, Henry Roland G, Pot Caroline, Matthias Amandine, Salmen Anke, Oksenberg Jorge R, Giulio Disanto, Zecca Chiara, D'Souza Marcus, Du Pasquier Renaud A, Bridel Claire, Gobbi Claudio, Kappos Ludwig, Hauser Stephen L, Cree Bruce A C, Kuhle Jens, Green Ari J, UCSF, MS EPIC, and the SMSC Study Teams

more
Nov 6, 2023
Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
Philippen L, Schub N, Günther A, Cario G, Schrappe M, Repp R, Gramatzki M. Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease. Bone Marrow Transplant 2023; 59:153-155.
Nov 6, 2023
Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
Nov 6, 2023

Bone Marrow Transplant 2023; 59:153-155

Philippen Lennart, Schub Natalie, Günther Andreas, Cario Gunnar, Schrappe Martin, Repp Roland, Gramatzki Martin

more
Nov 4, 2023
Exploring Capabilities of Large Language Models such as ChatGPT in Radiation Oncology.
Dennstädt F, Hastings J, Putora P, Vu E, Fischer G, Süveg K, Glatzer M, Riggenbach E, Hà H, Cihoric N. Exploring Capabilities of Large Language Models such as ChatGPT in Radiation Oncology. Adv Radiat Oncol 2023; 9:101400.
Nov 4, 2023
Exploring Capabilities of Large Language Models such as ChatGPT in Radiation Oncology.
Nov 4, 2023

Adv Radiat Oncol 2023; 9:101400

Dennstädt Fabio, Hastings Janna, Putora Paul Martin, Vu Erwin, Fischer Galina, Süveg Krisztian, Glatzer Markus, Riggenbach Elena, Hà Hông-Linh, Cihoric Nikola

more
Nov 2, 2023
Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia.
Agema B, Buck S, Viskil M, Isebia K, de Neijs M, Sassen S, Koch B, Jörger M, de Wit R, Koolen S, Mathijssen R. Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia. Eur Urol Oncol 2023
Nov 2, 2023
Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia.
Nov 2, 2023

Eur Urol Oncol 2023

Agema Bram C, Buck Stefan A J, Viskil Mano, Isebia Khrystany T, de Neijs Micha J, Sassen Sebastiaan D T, Koch Birgit C P, Jörger Markus, de Wit Ronald, Koolen Stijn L W, Mathijssen Ron H J

more
Nov 1, 2023
Author Correction: Patient-reported perioperative anaesthesia-related anxiety is associated with impaired patient satisfaction: a secondary analysis from a prospective observational study in Switzerland.
Bello C, Nübling M, Koster K, Heidegger T. Author Correction: Patient-reported perioperative anaesthesia-related anxiety is associated with impaired patient satisfaction: a secondary analysis from a prospective observational study in Switzerland. Sci Rep 2023; 13:18828.
Nov 1, 2023
Author Correction: Patient-reported perioperative anaesthesia-related anxiety is associated with impaired patient satisfaction: a secondary analysis from a prospective observational study in Switzerland.
Nov 1, 2023

Sci Rep 2023; 13:18828

Bello Corina, Nübling Matthias, Koster Kira-Lee, Heidegger Thomas

more
Nov 1, 2023
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria
Rodríguez D, Gurevich E, Mohammadi Jouabadi, Pastor Arroyo E, Ritter A, Estoppey Younes S, Wagner C, Imenez Silva P, Seeger H, Mohebbi N. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria. Clinical Kidney Journal 2023
Nov 1, 2023
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria
Nov 1, 2023

Clinical Kidney Journal 2023

Rodríguez Daniel, Gurevich Ekaterina, Mohammadi Jouabadi Soroush, Pastor Arroyo Eva Maria, Ritter Alexander, Estoppey Younes Sandrine, Wagner Carsten A, Imenez Silva Pedro H, Seeger Harald, Mohebbi Nilufar

more
Nov 1, 2023
Incidence and prognosis of contralateral vocal fold paralysis after hemithyroidectomy in previously unoperated patients.
Sinz S, Grafen F, Kolb W, Rosenfeld J, Clerici T. Incidence and prognosis of contralateral vocal fold paralysis after hemithyroidectomy in previously unoperated patients. BJS Open 2023; 7
Nov 1, 2023
Incidence and prognosis of contralateral vocal fold paralysis after hemithyroidectomy in previously unoperated patients.
Nov 1, 2023

BJS Open 2023; 7

Sinz Stefanie, Grafen Franziska, Kolb Walter, Rosenfeld Jochen, Clerici Thomas

more
Nov 1, 2023
NT-proBNP or Self-Reported Functional Capacity in Estimating Risk of Cardiovascular Events After Noncardiac Surgery.
Lurati Buse G, Larmann J, Gillmann H, Kotfis K, Ganter M, Bolliger D, Filipovic M, Guzzetti L, Chammartin F, Mauermann E, Ionescu D, Szczeklik W, De Hert S, Beck-Schimmer B, Howell S, METREPAIR NTproBNP Subcohort Investigators. NT-proBNP or Self-Reported Functional Capacity in Estimating Risk of Cardiovascular Events After Noncardiac Surgery. JAMA Netw Open 2023; 6:e2342527.
Nov 1, 2023
NT-proBNP or Self-Reported Functional Capacity in Estimating Risk of Cardiovascular Events After Noncardiac Surgery.
Nov 1, 2023

JAMA Netw Open 2023; 6:e2342527

Lurati Buse Giovanna A L, Larmann Jan, Gillmann Hans-Jörg, Kotfis Katarzyna, Ganter Michael T, Bolliger Daniel, Filipovic Miodrag, Guzzetti Luca, Chammartin Frédérique, Mauermann Eckhard, Ionescu Daniela, Szczeklik Wojciech, De Hert Stefan, Beck-Schimmer Beatrice, Howell Simon, METREPAIR NTproBNP Subcohort Investigators

more
Nov 1, 2023
Objective estimation of colonic transit time using radiopaque markers in an abdominal X-ray after laparoscopic colorectal resection: secondary analysis of a randomized clinical trial.
Ammann Y, Warschkow R, Bischofberger S, Ukegjini K, Tarantino I, Steffen T. Objective estimation of colonic transit time using radiopaque markers in an abdominal X-ray after laparoscopic colorectal resection: secondary analysis of a randomized clinical trial. BJS Open 2023; 7
Nov 1, 2023
Objective estimation of colonic transit time using radiopaque markers in an abdominal X-ray after laparoscopic colorectal resection: secondary analysis of a randomized clinical trial.
Nov 1, 2023

BJS Open 2023; 7

Ammann Yanic, Warschkow Rene, Bischofberger Stephan, Ukegjini Kristjan, Tarantino Ignazio, Steffen Thomas

more
Nov 1, 2023
Tumour, narrow pelvis and surgery specific factors for total mesorectal excision quality and morbidity following rectal cancer resection.
Tschann P, Brock T, Weigl M, Clemens P, Brunner W, Attenberger C, Königsrainer I, Emmanuel K, Jäger T. Tumour, narrow pelvis and surgery specific factors for total mesorectal excision quality and morbidity following rectal cancer resection. BJS Open 2023; 7
Nov 1, 2023
Tumour, narrow pelvis and surgery specific factors for total mesorectal excision quality and morbidity following rectal cancer resection.
Nov 1, 2023

BJS Open 2023; 7

Tschann Peter, Brock Thomas, Weigl Markus, Clemens Patrick, Brunner Walter, Attenberger Christian, Königsrainer Ingmar, Emmanuel Klaus, Jäger Tarkan

more
Nov 1, 2023
Ultrasound Doppler technique for the diagnosis of focal nodular hyperplasia – case series and systematic review
Sawatzki M, Baumeler S, Semela D. Ultrasound Doppler technique for the diagnosis of focal nodular hyperplasia – case series and systematic review. Med Ultrason 2023; Online first:1-11.
Nov 1, 2023
Ultrasound Doppler technique for the diagnosis of focal nodular hyperplasia – case series and systematic review
Nov 1, 2023

Med Ultrason 2023; Online first:1-11

Sawatzki Mikael, Baumeler Stephan, Semela David

more
Nov 1, 2023
A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up.
Padevit L, Vasella F, Friedman J, Mutschler V, Jenkins F, Held U, Rushing E, Wirsching H, Weller M, Regli L, Neidert M. A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up. Front Oncol 2023; 13:1279933.
Nov 1, 2023
A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up.
Nov 1, 2023

Front Oncol 2023; 13:1279933

Padevit Luis, Vasella Flavio, Friedman Jason, Mutschler Valentino, Jenkins Freya Sophie, Held Ulrike, Rushing Elisabeth Jane, Wirsching Hans-Georg, Weller Michael, Regli Luca, Neidert Marian Christoph

more
Nov 1, 2023
Correction to: The influence of lunar phases and zodiac sign 'Leo' on perioperative complications and outcome in elective spine surgery.
Joswig H, Stienen M, Hock C, Hildebrandt G, Surbeck W. Correction to: The influence of lunar phases and zodiac sign 'Leo' on perioperative complications and outcome in elective spine surgery. Acta Neurochir (Wien) 2023; 165:3529.
Nov 1, 2023
Correction to: The influence of lunar phases and zodiac sign 'Leo' on perioperative complications and outcome in elective spine surgery.
Nov 1, 2023

Acta Neurochir (Wien) 2023; 165:3529

Joswig Holger, Stienen Martin N., Hock Carolin, Hildebrandt Gerhard, Surbeck Werner

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy